Vortex Surgical Recalls I2 Injection Kits Over Potential Sterility Breach
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Vortex Surgical Inc. is recalling 14,789 I2 Injection Kits due to packaging seal defects that could compromise sterility and lead to patient infection.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references Worldwide. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, MedicalDevices.
What Happened
Vortex Surgical Inc. has initiated a voluntary recall of the Vortex Surgical I2 Injection Kit (Model VS0500). The recall was prompted by the discovery of potential voids in the seals of the Tyvek pouches used for the kits. These defects could compromise the sterile barrier of the medical device, potentially leading to bioburden contamination and subsequent patient infection.
Which Products Are Affected
The recall involves the following specific product details:
- Product Name: Vortex Surgical I2 Injection Kit, VS0500
- Recall Number: Z-1252-2026
- Lot Number: 2411012
- Pouch UDI: 810123480920
- Box UDI: 810123481330
A total of 14,789 units are affected, including 8,651 units distributed within the United States and 6,138 units distributed internationally. In the U.S., the product was distributed to 31 states: AL, AR, AZ, CA, CT, FL, HI, IA, IL, IN, KY, MA, MI, MN, MS, NC, NE, NJ, NM, NY, OH, OR, PA, RI, SC, SD, TN, TX, WA, WI, and VA. International distribution included Australia, Chile, China, France, Germany, India, Ireland, Italy, Japan, Korea, Mexico, Netherlands, Philippines, Poland, Puerto Rico, Spain, Switzerland, Taiwan, United Kingdom, and Vietnam.
What You Should Do
Vortex Surgical Inc. began notifying affected customers via a letter sent on December 16, 2025. Healthcare facilities and distributors should immediately check their inventory for Lot 2411012 and sequester any remaining units to prevent use. For information regarding returns or further instructions, contact Vortex Surgical Inc. at their headquarters: 4 Research Park Dr Ste 124, Saint Charles, MO 63304.
Why This Matters
The integrity of a sterile barrier is critical for medical devices used in surgical procedures. Voids in the packaging seal can allow microorganisms to contaminate the device, posing a serious risk of infection to patients during clinical use.
Source
This information is based on an official recall report from the FDA.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.